GlassScriptPhysician profile
Lara Renee Hart
NPI 1154594679
$2,735.86
in general payments reported to CMS, 2019-2025
30 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $618 · 2020: $49.09 · 2021: $130 · 2022: $40.07 · 2023: $1,139 · 2024: $421 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,140 · Travel and Lodging: $758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,140.30 |
| Travel and Lodging | $757.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $959.00 | 2023-2024 | Da Vinci Surgical System |
| Astellas Pharma US INC | $428.67 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $355.03 | 2019-2024 | |
| Minerva Surgical, INC | $140.09 | 2019 | |
| Roche Diagnostics Corporation | $137.79 | 2019 | |
| Coopersurgical, INC. | $60.91 | 2019-2025 | Paragard T 380a |
| Therapeuticsmd, INC. | $59.09 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.42 | 2023-2024 | |
| Exeltis, USA INC. | $50.53 | 2019-2024 | Slynd |
| Amag Pharmaceuticals, INC. | $48.92 | 2019 | |
| Dexcom, INC. | $40.94 | 2023-2025 | Dexcom G6 Transmitter |
| Organon LLC | $40.78 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $40.07 | 2019-2024 | Gardasil 9, Gardasil |
| Amgen INC. | $32.20 | 2024-2025 | Evenity, Prolia, Prolia |
| Hologic Sales and Service, LLC | $31.80 | 2020-2025 | Aptima |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $28.84 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Biogen, INC. | $28.69 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $24.44 | 2023 | Phexxi |
| Covidien LP | $21.47 | 2019 | |
| Baxter Healthcare | $18.65 | 2019 | |
| Exact Sciences Corporation | $17.81 | 2024 | Cologuard Collection Kit |
| Olympus America INC. | $15.43 | 2024 | Uretero-Reno Fiberscope, Berkeley |
| Medtronic, INC. | $14.43 | 2024 | Stealthstation S8 Platform |
| Sumitomo Pharma America, INC. | $14.35 | 2025 | Myfembree |
| Vertical Pharmaceuticals, LLC | $13.86 | 2019 | |
| Allergan, INC. | $13.82 | 2020 | |
| Pfizer INC. | $12.71 | 2022 | |
| Lupin INC. | $12.48 | 2019 | |
| Ethicon US, LLC | $11.80 | 2022 | |
| Mayne Pharma Commercial LLC | $8.84 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lara Hart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.